TwoexperimentalvaccinesagainsttheEbolavirushaveshownpromiseinprotectingagainstthehemorrhagicfeverforatleastayear,accordingtotheresultsofamajorclinicaltrialpubli
Twoexperimentaltreatmentsforskincancer,tailor-madetotargetaparticularpatient'stumours,provedsafeinsmall-scaletrials,theirdevelopersreportedWednesday.Thevaccines
The Dengvaxia vaccine has been tested on a million children in the Philippines, in a 3.5-billion-peso (S$98 million) state-sponsored immunisation programme that began in April last year.
On World Polio Day, which falls on Oct. 24, UN spokesman Stephane Dujarric said that since the establishment of the Global Polio Eradication Initiative (GPEI) in 1988, polio worldwide has been reduced by 99 percent.
If approved, an HPV vaccine currently in the final stages of clinical testing should be available in China within two years, said the developer on Thursday.
GlaxoSmithKline's human papilloma virus vaccine has been approved for sale, China Food and Drug Administration told Xinhua on Monday.
Wholesalers are no longer allowed to trade vaccines following a case involving the sale of millions of dollars' worth of improperly stored vaccines, according to a government decision publicized Monday.
The State Council has announced that 357 officials implicated in cases concerning the illegal sale of improperly stored vaccines would be penalized.
As public health officials warn that the Zika virus is swiftly spreading across the Americas, the search is on to develop a vaccine to halt the disease, which could infect as many as four million people by the end of the year and has been linked to severe birth defects.
A private Chinese biotechnology company plans to mass produce a vaccine against the Ebola virus developed by Chinese military scientists.
A large clinical trial to assess the safety and efficacy of two Ebola vaccines began in the West African country of Liberia on Monday, said the U.S. National Institutes of Health (NIH), which sponsored the research.
China's drug watchdog has licensed a new vaccine against the poliomyelitis, the Ministry of Science and Technology announced Thursday.
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine, aiming to have vaccinated all 72 healthy adult volunteers by the end of January.
There is no evidence that Fluad, a flu vaccine manufactured by Swiss multinational pharmaceutical company Novartis, has caused serious events including deaths in Italy, the European Medicines Agency (EMA) said in a statement on Wednesday.
Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the epidemic, a scientist from Oxford University said Monday.
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a phase one clinical trial, the U.S. National Institutes of Health ( NIH) said Wednesday.
A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University in Britain, generating strong and broad immune responses, according to the results published Wednesday in the journal Science Translational Medicine.
简体中文
